ORAGENICS INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Oragenics Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2024.
  • Oragenics Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $1.65M.
  • Oragenics Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $284K.
  • Oragenics Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$495K, a 102% decline from 2021.
  • Oragenics Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $23.1M, a 41.8% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.65M +$1.81M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 -$160K +$21.5K +11.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 -$181K -$23.4M -101% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $23.2M +$23.3M Jan 1, 2021 Mar 31, 2021 10-Q/A 2023-04-14
Q1 2020 -$73K -$11.4M -101% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q1 2019 $11.4M +$11.4M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q1 2018 -$41.6K -$36.7K -741% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q1 2017 -$4.95K +$29K +85.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 -$33.9K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q1 2013 $5.26K -$1.93M -99.7% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q1 2012 $1.94M +$891K +85.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q1 2011 $1.05M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.